All News

FDA Approves Ophthalmic Solution for Treatment of Cystinosis

Drops of cysteamine ophthalmic solution are applied 4 times a day.

Study Finds Rates of E-Cigarettes, Marijuana Use Not Associated With Vaping-Related Lung Injuries

The results showed higher rates of vaping and marijuana use are associated with fewer EVALI cases per capita.

Department of Defense Awards Adaptive Phage Therapeutics $9.8 Million for Development of COVID-19 Vaccine

The Department of Defense awarded Adaptive Phage Therapeutics $9.8 million for the development of multiple high-priority, bacteriophage-based display vaccine candidates against COVID-19.

Study: COVID-19 Pandemic Causing Mental Health Issues

Over the course of the COVID-19 pandemic, Google searches for anxiety have climbed 17%.

Peanut Allergy Study Emphasizes Impact of Avoidance, Fear of Accidental Reaction

Many caregivers reported that their child’s peanut allergy negatively impacts their job or career, suggesting potential socioeconomic impacts on families.

Study: Defiance, Low Trust in Medical Doctors Related to Vaccine Skepticism

Negative feelings toward vaccines may be caused by the recommendations given by authorities or social pressure in society to get vaccinated, according to a study.

Flu Shots Now Available at All Walgreens Pharmacies

Walgreens is now offering flu shots daily at all of its nearly 9100 pharmacies, with additional safety measures in place that follow the CDC’s recommendations for anyone over 6 months of age to get the flu shot.

MJH Life Sciences™ Hosts Expert-Driven 'Debating the Road Back to School' Live Webinar

To support pediatricians, pharmacists and primary care physicians as schools reopen during the pandemic, MJH Life Sciences™ today announced it will host “Debating the Road Back to School,” a free, live, one-hour webinar on Thursday, Aug. 20, at 6 p.m. EDT.

100 Million Doses of Experimental COVID-19 Vaccine to be Produced Under New US-Moderna Deal

Moderna will manufacture doses of its experimental coronavirus disease 2019 vaccine candidate as clinical trials are ongoing to expedite the production process.

FDA Approves New Opioid for Intravenous Use in Hospital Setting

The FDA has approved olicerdine (Olinvyk, Trevena) for use in patients with severe pain who require an IV opioid when alternative treatments prove to be inadequate.